These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 19463228)

  • 1. [Cutaneous drug reactions in HIV-infected patients in the HAART era].
    Blanes M; Belinchón I; Portilla J
    Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
    Kong HH; Myers SA
    Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe dyshidrosis in two patients with HIV infection shortly after starting highly active antiretroviral treatment.
    Colebunders R; Zolfo M; Lynen L
    Dermatol Online J; 2005 Aug; 11(2):31. PubMed ID: 16150239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recurring cutaneous drug reactions in patients with human immunodeficiency virus 1 infection: a series of 3 cases.
    Dolev J; Reyter I; Maurer T
    Arch Dermatol; 2004 Sep; 140(9):1051-3. PubMed ID: 15381543
    [No Abstract]   [Full Text] [Related]  

  • 5. Critical care of HIV infected patients in the highly active antiretroviral therapy era.
    Corona A; Raimondi F
    Minerva Anestesiol; 2007 Dec; 73(12):635-45. PubMed ID: 18046294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART).
    Authier FJ; Chariot P; Gherardi RK
    Muscle Nerve; 2005 Sep; 32(3):247-60. PubMed ID: 15902690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.
    Klibanov OM; Clark-Vetri R
    Pharmacotherapy; 2007 Jan; 27(1):122-36. PubMed ID: 17192166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions associated with HAART: focus on treatments for addiction and recreational drugs.
    Faragon JJ; Piliero PJ
    AIDS Read; 2003 Sep; 13(9):433-4, 437-41, 446-50. PubMed ID: 14598790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous drug reactions associated with newer antiretroviral agents.
    Martins CR
    J Drugs Dermatol; 2006; 5(10):976-82. PubMed ID: 17373147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side effects of antiretroviral therapy].
    Teodor A; Teodor D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):23-6. PubMed ID: 15688751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of depression on HIV outcomes in the HAART era.
    Hartzell JD; Janke IE; Weintrob AC
    J Antimicrob Chemother; 2008 Aug; 62(2):246-55. PubMed ID: 18456650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of transplantation in HIV patients during the HAART era.
    Pelletier SJ; Norman SP; Christensen LL; Stock PG; Port FK; Merion RM
    Clin Transpl; 2004; ():63-82. PubMed ID: 16704139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
    Magen E; Elbirt D; Sthoeger Z
    Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
    Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
    Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
    dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
    J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: current status of liver transplantation in HIV-infected patients.
    Neff GW; Sherman KE; Eghtesad B; Fung J
    Aliment Pharmacol Ther; 2004 Nov; 20(10):993-1000. PubMed ID: 15569101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
    Burgoyne RW; Tan DH
    J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era.
    Nguyen BY; Reveille JD
    Curr Opin Rheumatol; 2009 Jul; 21(4):404-10. PubMed ID: 19444116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.
    Patel AK; Patel K; Patel J
    J Assoc Physicians India; 2004 Aug; 52():666-9. PubMed ID: 15847366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.